Q/C Technologies, Inc., formerly TNF Pharmaceuticals, Inc., is focused on blockchain infrastructure. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The Company bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.
Company Information
About this company
Key people
Joshua N. Silverman
Executive Chairman of the Board
Ian Rhodes
Interim Chief Financial Officer
Mitchell Glass
Chief Medical Officer, Director
Bruce Bernstein
Director
Christopher C. Schreiber
Director
Chelsea Voss
Director
Stephen Friscia
Independent Director
Bill Joe White
Independent Director
Click to see more
Key facts
- Shares in issue4.17m
- EPICQCLS
- ISINUS62856X3008
- LocationUnited States
- SectorTechnology
- IndustrySoftware & Programming
- Market cap$15.42m
- Employees2
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.